homologous members [3] [4] [5] [6] . These CDKs are conThe effect of the cyclin-dependent (CDK) inhibitors stantly expressed during the cell cycle, but their activolomoucine and roscovitine on cell kinetics was stud-ity is tightly regulated by complex formation with ied. To this end, nonsmall cell lung cancer (NSCLC) cyclins, a class of proteins which also consists of several cell line MR65 and neuroblastoma cell line CHP-212 highly homologous members [5] [6] [7] . In contrast to were pulse labeled with bromodeoxyuridine (BrdUrd) CDKs, cyclins are periodically expressed during the difand chased in culture medium, to which various con-ferent phases of the cell cycle [7, 8] . For instance, the centrations of olomoucine or roscovitine were added. mitotic cyclin B is expressed very late in the S-phase A dose-dependent inhibition of the G 1 /S-phase and G 2 / and during G 2 -and part of the M-phase, while cyclin M-/G 1 transitions was observed. Furthermore, S-phase E is expressed during late G 1 and early S-phase of the progression was also inhibited in a dose-dependent cell cycle [9-13].
INTRODUCTION
sulting in phosphorylation and activation of the CDC25-C by CDK-cyclin B [20] and phosphorylation The carefully ordered progression through the cell and inactivation of weel. At the same time the active cycle is tightly controlled by the sequential formation, CDK/cyclin complex is involved in activating compoactivation, and inactivation of a series of cell cycle regunents of the cyclin-ubiquitin ligase pathway [21] , relating kinases [1, 2] . Key players in the regulation of sulting in its inactivation. This inactivation of the the cell cycle are the cyclin-dependent kinases (CDKs), CDK/cyclin complexes is brought about by rapid proteoa family of serine/threonine kinases with several highly lytic breakdown of the cyclins [22] , mediated through the ubiquitin degradation pathway [21, 23, 24] .
[25]. For instance, evidence exists that the CDK1/cyclin and a similar efficiency toward erk1 and the other kinases tested) on the cell kinetics of two cell lines. To B complex is responsible for phosphorylation of the lamins during mitosis [26] , which results in the dissoci-this end cells were pulse labeled with the thymidine analogue bromodeoxyuridine (BrdUrd) and chased in ation of the nuclear lamina. On the other hand, the CDK4/cyclin D complex seems to govern the G 1 transi-normal culture medium supplemented with various doses of inhibitor. Evidence was found for a dose-depention by phosphorylating the RB gene product [27, 28] . The CDK2/cyclin E kinase plays an essential role in dent inhibition of cell cycle phase transition rates in both cell lines. At the highest doses tested, both olo-G1/S transition [10, 29] . Physical association of cyclin A with transcription factor E2F has been found, which moucine and roscovitine induced an almost complete arrest of cells in their specific cell cycle phase, which implicates a role of CDK/cyclin complexes in regulation of transcription [30, 31] . Furthermore, biochemical evi-ultimately resulted in apoptosis. No evidence was found for a cell cycle phase-specific induction of dence exists for a role of the CDK2/cyclin A complex during DNA replication, since this complex is able to apoptosis by olomoucine or roscovitine. phosphorylate a replication factor in vitro [32] . Furthermore, immunocytochemical analysis revealed that
MATERIALS AND METHODS
cyclin A colocalizes with replication sites [33, 34] .
Cell lines. The human nonsmall cell lung cancer (NSCLC) cell
Many putative target proteins have been identified line MR65, kindly supplied by Dr. Gropp (Philips Universiẗats for cyclin-dependent kinase complexes in cell-free sys-Klinik, Marburg, Germany), was cultured in Eagle's modified minitems [1, 2, 35] . However, little information exists on the mal essential medium (GIBCO, Paisley, Scotland), supplemented in vivo targets of the CDK/cyclin complexes. Recently, with 1% nonessential amino acid solution (GIBCO), 1% glutamine (Serva, Heidelberg, Germany; No. 22942), 1% HEPES (GIBCO), 10% intrinsic CDK inhibitors have been identified, such as heat-inactivated newborn calf serum (GIBCO, 021-6010M), and 0.1% p21 CIP1/WAF1 and others [36, 37] . The expression of, gentamycin (AUV, Cuyck, The Netherlands). The human neurofor instance, p21 is under the control of the p53 protein blastoma cell line CHP-212 [42] was cultured in Dulbecco's modified and functions to arrest the cells at the G 1 -phase of the medium (GIBCO), supplemented with 1% glutamine (Serva), 10% cell cycle in response to DNA damage [38] . By influenc-heat-inactivated newborn calf serum, and 0.1% gentamycin (AUV).
Cells were harvested during exponential growth by trypsinization.
ing the transcription of these intrinsic inhibitors it
BrdUrd pulse/chase labeling. The cell lines were pulse labeled would be possible to elucidate the role of these CDK/ with 10 mM BrdUrd (Serva, Heidelberg, Germany) for 30 min, rinsed cyclin complexes in vivo and identify the target pro-twice in prewarmed PBS, and chased in prewarmed culture medium, teins that are affected by these complexes. An alterna-supplemented with 5 mM deoxythymidine. tive approach would be to use extrinsic inhibitors of CDK inhibitor treatment. Olomoucine and roscovitine were disthese kinases but so far the availability of specific in-solved in DMSO and added to the cell cultures after BrdUrd pulse labeling, at various concentrations i.e., 10, 50, 100, and 200 mM for hibitors of these complexes has been limited. Recently, it was shown that a compound isolated DMSO concentration in the culture medium was 2%. Control cultures from Aspergillus terreus, name butyrolactone I, was received 2% DMSO. At various time intervals cells were harvested able to inhibit several CDK/cyclin complexes in vitro by collecting both the floating as well as the adherent cells. Part and in vivo [39] . The authors showed that butyrolac-of the cell suspension was centrifuged onto glass slides, while the remainder of the suspension was fixed in 70% ethanol at 4ЊC and tone I was able to inhibit the phosphorylation of Rb used for bivariate BrdUrd/DNA flow cytometric analysis.
both in vitro and in vivo. Recently, Vesely et al. [40] Immunocytochemistry. Incorporated BrdUrd was detected as dedescribed a new purine derivative, olomoucine (2-(hy-scribed previously [43] . Briefly, approximately 10 6 ethanol-fixed cells droxyethylamino)-6-benzylamino-9-methylpurine), were rinsed once in PBS and resuspended in 2 ml of 0.4 mg/ml pepsin which acts as a potent inhibitor of the CDK1/cyclin B in 0.1 N HCl (Serva, Heidelberg, Germany). After 30 min at room temperature cells were pelleted, resuspended in 2 N HCl, and incuand related kinases by competing for the ATP binding bated for another 30 min at 37ЊC. Cells were rinsed in 0.1 M borate domain of the kinase [40, 41] . Of 35 protein kinases buffer, pH 8.5, and PBS/BSA (1 mg/ml BSA in PBS). Appropriately tested, olomoucine inhibited CDK2/cyclin A, CDK2/ diluted anti-BrdUrd antibody (clone IIB5, available form Euro-Diagcyclin E, CDK1/cyclin B, CDK5/p35, and erk1. The re-nostica B. V., Arnhem, The Netherlands) was added to the cell pellet, lated kinases CDK4/cyclin D and CDK6/cyclin D3 were resuspended in 100 ml PBS/BSA. After incubation for 1 h at room temperature, the cells were rinsed twice in PBS/BSA. For visualizanot inhibited or were less sensitive to olomoucine. This tion, FITC-conjugated Fab 2 fragments of rabbit anti-mouse Ig new compound showed no effect on other kinases (DAKO A/S, Glostrup, Denmark) antibody were added in a 1:10 dilutested, such as protein kinases A or C, cyclic AMP-or tion. After incubation for 45 min at room temperature samples were cyclic GMP-dependent kinases, and many others, nor rinsed twice in PBS/BSA and the cells were finally resuspended in on several enzymes that are directly involved in DNA-0.5 ml cold PBS supplemented with 100 mg/ml RNAse (Serva) and 20 mg/ml propidium iodide (PI; Calbiochem, La Jolla, CA). The samsynthesis, such as DNA toposiomerases and DNA polyples were allowed to stand for 15 min on ice in the dark before flow merases at doses less than 1 mM. cytometric analysis. In the negative control the primary antibody
In this study we investigated in detail the effect of was omitted. olomoucine and roscovitine (an olomoucine analogue For bivariate CDK1/DNA analysis cells were fixed in methanol for 5 min at 020ЊC. After rinsing the cells in PBS/BSA the resuspended with 10-fold higher efficiency toward CDK1 and CDK2 pellet was incubated for 1 h at RT with anti-cdc2 (SC-54, Santa Cruz Biotechnologies Inc., 1:20), followed by rinsing twice in PBS/BSA. Monoclonal antibody binding was visualized by incubating the cells with FITC-conjugated Fab 2 fragments of rabbit anti-mouse Ig (DAKO A/S, Glostrup, Denmark) antibody in a 1:10 dilution. After incubation for 45 min at room temperature samples were rinsed twice in PBS/BSA and the cells were finally resuspended in 0.5 ml cold PBS supplemented with 100 mg/ml RNAse (Serva) and 20 mg/ ml propidium iodide (PI; Calbiochem, La Jolla, CA). The samples were allowed to stand for 15 min on ice in the dark before flow cytometric analysis.
Cells, which were cytocentrifuged onto glass slides, were fixed for 5 min in cold methanol at 020ЊC, rinsed in PBS, stained with PI (1 mg/ml in PBS) for 10 min at room temperature, and embedded in glycerol/DABCO/PI (9 parts of glycerol, 1 part of 0.2 M HCl, pH 8.0, 0.02% NaN 3 , and 2% DABCO (1,4-di-azobicyclo-(2,2,2)-octane, Merck, Darmstadt, Germany; no. 803456), pH 8.0) containing 0.5 mg/ ml PI. The slides were covered with a coverslip and sealed with nail polish.
Flow cytometry. For flow cytometric analysis a FACSort (BectonDickinson, Sunnyvale, CA) equipped with a single Argon ion laser was used. Excitation was done at 488 nm, and the emission filters used were 515-545 BP (green; FITC), 572-588 BP (orange; PE), and 600 LP (red; PI). A minimum of 10,000 cells per sample were ana- the mean DNA content of BrdUrd-positive/undivided cells (R2) and Data analysis was performed with the standard Lysis and Cellfit BrdUrd-negative G 1 and S-phase cells (R6) or to quantitate the numsoftware (Becton-Dickinson). As a standard procedure for all analy-ber of BrdUrd-positive/divided cells (R3), BrdUrd-negative G 2 /Mses, data were gated on pulse-processed PI signals to exclude dou-phase cells (R4), and BrdUrd-negative G 1 -phase cells (R5). These blets and larger aggregates.
data are used to calculate the progression through various cell cycle For detailed cell kinetic analysis, five cell cycle compartments were compartments as outlined under Materials and Methods. identified as described by Higashikubo et al. [44] . Briefly, the following populations were quantified (see Photography. Phase contrast images of cell cultures were taken reflecting the modes of cell progression through the cell cycle were using an Axiovert 35 M microscope (Zeiss, Oberkochen, Germany), determined:
equiped with a Nikon camera. For this purpose an Agfa pan 25X (i) relative movement of the cells through the S-phase (RM, acblack and white film was used. cording to Begg et al. [45] ); i.e., the mean DNA content of BrdUrdGel electrophoresis and immunoblotting. Cell samples were repositive undivided population normalized to G 1 and G 2 /M peak posi-suspended in 50 mM Tris-HCl, pH 7.4, containing 17% glycerol and tion Å (X lu 0 X G1 )/(X G2/M 0 X G1 ); 2 mM ATP and sonicated for 5 s at 0ЊC. Samples were centrifuged (ii) fraction of undivided cells among the BrdUrd-positive popula-at 4ЊC and the supernatant and pellet fraction were split. These were tion (F / undivided) Å N lu /(N lu / N ld /2); boiled for 5 min in SDS-sample buffer and loaded onto denaturing
12% polyacrylamide gels [46] . The equivalent of approximately 10 6 (iv) the position of negative cells excluding the initial G 2 /M cells cells was used per lane. Gels were run on the Mini-Protean II system normalized to G 1 
(Bio-Rad Laboratories) for approximately 45 min at 200 V.
Immunoblotting was performed according to the method of Towbin Data analysis. The means of the four parameters were plotted et al. [47] , using PVDF membranes (Schleicher and Schuell, Dassel, as a function of time after BrdUrd pulse labeling for each dose of Germany). The blots were incubated with anti-cdc2 (sc-54, Santa olomoucine and roscovitine tested. To quantitatively assess cell cycle Cruz Biotechnologies Inc.), washed with PBS, and subsequently incuprogression, linear portions of the kinetic curves were fitted by linear bated with a peroxydase-conjugated rabbit anti-mouse Ig antibody regression analysis. For the BrdUrd-negative G2/M fractions the lin-(DAKO A/S) to detect primary antibody binding. Peroxydase reactivear regression analysis was performed on the logarithmically transity was detected by enhanced chemiluminescence (ECL-kit, Amerformed data. The slopes of the regression lines were used to elucidate sham, Buckinghamshire, UK). the changes in the rate of cell cycle progression.
Confocal scanning laser microscopy. Cells cytocentrifuged onto glass slides were analyzed using the MRC600 confocal scanning laser RESULTS microscope (Bio-Rad, Hemel Hempstead, UK), equipped with an aircooled Argon-Krypton mixed gas laser and mounted onto an AxioIn a first series of experiments in which the cell lines phot microscope (Zeiss, Oberkochen, Germany). The laser scan mi-MR65 and CHP212 were exposed to various concentracroscope was used in the dual parameter setup, according to the manufacturers specification, using dual wavelength excitation at 488 tions of the CDK inhibitor olomoucine and harvested at different time intervals, no obvious changes in cell partment. In the control cultures ( Fig. 2A) cells which were originally in the G 1 -phase of the cell cycle at the cycle phase distributions were observed (data not shown). The cultures seem not to be blocked in a spe-time of pulse labeling, have progressed through Sphase in contrast to the cultures exposed to olomoucine cific phase of the cell cycle by olomoucine. In order to investigate the cell cycle effects of this CDK inhibitor (Figs. 2B-2D ). At the highest dose of olomoucine, i.e., 200 mM, the cells seem to be frozen in the cell cycle. in more detail, the cell lines were pulse labeled with BrdUrd and chased in the presence of various concen-Furthermore, both in the BrdUrd-positive and -negative compartment, cells with a sub-G 1 DNA content trations of the drug. Figure 2 shows a series of bivariate BrdUrd/DNA cytograms of MR65 cells, chased for 10 seem to accumulate.
For a more detailed analysis the number of cells in h in the presence of 0, 50, 100, and 200 mM olomoucine. In contrast to the control culture ( Fig. 2A) , in which the various regions (R2-R6) of the scattergram were quantitated as outlined under Materials and Methods. the BrdUrd-labeled cells have progressed to G 2 /M and G 1 phase of the cell cycle, cells exposed to olomoucine Figure 3A shows the number of BrdUrd-negative G2/ M-phase cells (R5) as a function of time for the various lagged behind in the cell cycle in a dose-dependent manner. The number of BrdUrd-positive cells still in S-doses of olomoucine tested in MR65 cells. No dose or time-dependent differences in exit rate from this cell phase were higher with increasing dose of the inhibitor. Delayed cell cycle progression in the presence of olo-cycle compartment were observed up to a dose of 200 mM olomoucine, at which the exit rate from the G 2 / moucine was also obvious when analyzing the number of cells occupying the BrdUrd-negative S-phase com-M compartment declined. In contrast, for the BrdUrd- positive cells, the exit rate from the G2/M compartment showed a delayed G 2 /M phase transition rate. A possible explanation for this phenomenon could be the fact decreased in a dose-dependent fashion as is outlined in Fig. 3B . Similarly, the S-phase entry rate also de-that it takes some time for the cells to acquire a sufficient high intracellular dose of the inhibitor to be effeccreased in a dose-dependent manner (Fig. 3C) . No evidence is found for either a delayed entry of cells into tive. In order to test this hypothesis cell cultures were preincubated for 3 h with various doses of roscovitine G 1 -or S-phase in the presence of olomoucine, only the rate at which the cells progress is affected by the CDK prior to BrdUrd pulse labeling. The cultures were subsequently chased for 3 h and harvested. The decrease inhibitor. This is also the case for the progression of cells through the S-phase of the cell cycle as depicted in the number of BrdUrd-negative G2/M phase cells was normalized as compared to the control culture. As in Fig. 3D . At the highest dose of olomoucine tested; i.e., 200 mM the cells could be completely arrested in can be seen from Fig. 6 the decrease in the number of BrdUrd-negative G2/M-phase cells was less as the dose the S-phase.
The changes in cell cycle progression for both MR65 of roscovitine increased. In order to evaluate the CDK levels in MR65 cells, and CHP-212 cells were normalized and shown in Figs. 4A and 4B. Both cell lines showed similar dose-depen-incubated for various time periods in the presence of both inhibitors, cell lysates were prepared and subdent kinetic changes. The main effect of olomoucine is on the exit rates from G 1 -and G 2 /M phase of the cell jected to polyacrylamide gel electrophoresis followed by Western blotting. For both olomoucine and roscovitine cycle, while the progression rate through the S-phase of the cell cycle was affected to a lesser extend. Incuba-treated cells a decrease in total CDK1 protein levels were observed (Fig. 7 ). This decrease in the level of tion of MR65 cells with roscovitine showed exactly the same results. Figure 5 shows the differential dose-de-CDK1 protein was not due to a nonspecific effect of cell cycle inhibition since no decrease in protein levels was pendent effects of both olomoucine and roscovitine on G1-/S-phase transition and S-phase progression. How-found when the culture were exposed to hydroxyurea. This loss was confirmed by bivariate CDK1/DNA analyever, the ID50 values for roscovitin were 5-to 10-fold lower as compared to olomoucine. sis (Fig. 8A ) in which increasing amounts of CDK1-negative cells were detected when cells were cultured A contradictory finding for both CDK inhibitors was that the cells that were originally in the G 2 /M phase in the presence of increasing amounts of roscovitine.
Furthermore, the CDK1-negative cells showed characof the cell cycle at the time of BrdUrd administration progressed normally while the BrdUrd-positive cells teristics of apoptosis, i.e., loss of DNA (Fig. 8A) and The MR65 and CHP-212 cells showed different kinetics of induction of apoptosis at high olomoucine dose. Figure 10 shows that for MR65 cells the frequency of apoptotic cells gradually increased, with up to 50% apoptotic cells after 10 h at a dose of 200 mM olomoucine. In CHP-212 cultures the number of apoptotic figures increased rapidly after a 3-h lag time.
DISCUSSION
The molecular basis of activation and deactivation of CDKs is mainly elucidated in cell-free systems using purified components. In this way many target proteins are identified which are phosphorylated by different CDK/cyclin complexed in vitro [1, 2] . However, it is difficult to correlate events occurring on a molecular scale (e.g., activation) with those that occur on a cellular scale (e.g., the start of S-phase). Studies at the cellular level are largely hampered by the lack of specific inhibitors. Recently, Kitagawa et al. [39] , Losiewicz et al. [49] , and Vesely et al. [40] described specific inhibitors of certain CDKs (see review by Meijer [50] ).
In the present study a detailed analysis of the cell cycle effects of olomoucine was performed. To this end lated, based on the kinetics of the originally BrdUrdnegative G 2 /M phase cells, no effect was seen. This could be explained by the fact that a certain period of time is needed for a cell to accumulate a sufficiently altered scatter characteristics (data not shown). Again no loss of CDK1 immunoreactivity was observed when high intracellular dose of olomoucine to compete with ATP for the binding domain of the kinase. Exposing cells were exposed to hydroxyurea (Fig. 8B) .
When cell cultures, treated with highest dose of olo-the cells to the CDK inhibitor 3 h prior to the pulse labeling experiment resulted in a delayed progression moucine or roscovitine, were examined microscopically, many cells showed membrane blebbing and detached of BrdUrd-negative cells through G 2 /M, similar to that of BrdUrd-positive cells. No evidence was obtained for from the culture plastic. To examine these cells in more detail, they were harvested at various time intervals a delay in entry to or exit from the various cell cycle phases, suggesting that olomoucine remained active for and cytocentrifuged onto glass slides. The slides were stained with propidium iodide and the nuclear mor-prolonged periods of time or that the inhibiting effect was not reversible. The latter explanation is less likely, phology was examined using confocal scanning laser microscopy. Figures 9A-9D show phase contrast im-since evidence is provided by others [51] that the effect of olomoucine is easily reversible. ages of such MR65 cell cultures and confocal images of nuclear morphology of the corresponding cytocentriOne may argue that delayed progression through one cell cycle phase may affect the calculations on phase fuge preparations (Figs. 9E-9H ). With increasing time of exposure more cells showed membrane blebbing and transitions through the other cell cycle phases. For instance the rate of increase in the relative DNA content detachment from the culture dish. Simultaneously, the frequency of cells showing chromatin aggregation, typi-of G 1 /S cells unlabeled with BrdUrd does not reflect the G 1 /S transition alone, but is also affected by both the cal for apoptosis, increased. Some cells clearly showed chromatin condensation at the nuclear periphery, subsequent rate of DNA synthesis and the rate of division of BrdUrd-negative G 2 /M-phase cells to yield new while in the majority of cells the nucleus was completely broken down and only fragments of condensed G 1 -cells. However, the latter rate is identical for all experimental conditions except for the highest tested chromatin were seen. dose of inhibitor. Furthermore, the normalized data in cine having a 10-fold increased efficiency toward CDKs and a similar low efficiency toward erk1, showed ex- Fig. 5 shows that S-phase progression is only affected in a modest way, indicating that the rate of increase actly the same cell cycle effects, makes it very likely that the observed cell cycle effects are caused by direct in the relative DNA content of G 1 /S cells unlabeled with BrdUrd mainly reflects the G 1 /S transition alone. Simi-inhibition of CDKs in vivo rather than by inhibition of MAP kinases. Taken together, the data presented here larly, it can be shown that the division of BrdUrd-positive cells mainly reflects the G2/M transition and is are consistent with the hypothesis of a direct effect of olomoucine and roscovitine on both CDK2 and CDK1, only affected to a limited extent by the rate of completion of S-phase.
governing the G 1 -to S-phase and the G 2 /M-to G 1 -phase of the cell cycle, respectively [2, 7] . The finding that roscovitine, an analogue of olomouInterestingly, in both MR65 and CHP-212 cell lines a decreased S-phase progression rate was observed. Since this effect cannot be explained by a direct inhibition of DNA-polymerases by olomoucine (IC50s for these enzymes exceed 200 mM), a plausible explanation may be that CDKs play a direct role in DNA-synthesis. For example, Dutta et al. [32] reported that CDKs are able to phosphorylate RPA, a human cell DNA replication factor, and activate replication. In concordance with this finding, Vesely et al. [40] showed inhibition exposure of cells to hydroxyurea did not result in decreased levels of CDK1 protein levels.
To date, data on the role of CDKs during apoptosis are inconclusive. On the one hand, many authors provide evidence for activation of CDKs during apoptosis. In a study of Meikrantz et al. [55] the appearance of condensed chromatin was accompanied by a 2-to 7-fold increase in cyclin A-associated histone H1 kinase activity, where both CDK1 and CDK2 were activated. The authors suggested that cyclin A targets activated CDK1 and CDK2 to substrates necessary for chromatin condensation and other morphological changes during both apoptosis and mitosis. The authors also suggest that the sensitizing effect of cycloheximide, which was shown to occur in the MR65 NSCLC cell line [56] , would be due to its ability to increase cyclin A-associated ki- liferating cells and cells undergoing apoptosis, the cyclin A (but not B, C, D1, and E) mRNA level was elevated in unsynchronized myc-overexpressing cells of DNA synthesis in cell-free assays. Also, the p21 in-when compared with parental rat fibroblasts. hibitor of cylin-dependent kinases has been found in On the other hand, recent evidence suggests that association with PCNA, an auxillary protein for the PITSLRE kinase isoforms are cellular targets for cas-DNA-polymerase d. In addition, Cardoso et al. [33] and pase-3-mediated cleavage during TNF-induced apopSobczak-Thepot et al. [34] showed by means of immu-tosis [63] . Furthermore, Yoshida et al. [64] showed evinocytochemistry that cyclin A specifically localizes at dence that staurosporine-induced apoptosis is not acsubcellular sites of DNA replication.
companied by intracellular activation of CDK1. Also When cell cultures were grown in the presence of a the observation made by Guagdagno [60] seem to conhigh dose of olomoucine, many cells detached from the tradict a need for CDK activation during apoptosis. culture disk. Based on morphological criteria, such as They showed that the appearance of cyclin A messencell shrinkage, membrane blebbing, chromatin condenger RNA and protein in late G 1 was dependent on cell sation, and loss of DNA, as evidenced by bivariate adhesion. It is also known that prevention of substrate BrdUrd/DNA flow cytometric analysis, these cells attachment leads to apoptosis by a process named anshowed the characteristic features of apoptosis. In adoikis, a term derived from the Greek word for homedition, in a separate series of experiments we were able lessness [61] . to show another characteristic feature of apoptosis, In the presented study apoptosis was induced by innamely loss of membrane assymetry [52] , as measured hibiting CDKs. An explanation for the apparent disby phosphatidylserine exposure at the outer cytocrepancies of many studies might be that activation plasmic membrane, in combination with an intact or inhibition of CDKs per se is not associated with membrane integrity [53] .
apoptosis, but untimely activation or deactivation of The presented data suggest a direct link between these kinases, implying that cyclins and CDKs are in-CDK inhibition and induction of apoptosis, as recently volved at an important nodal point shared by pathways suggested by Park et al. [54] . Exposing cells to high regulating cellular proliferation and apoptosis. In line doses of CDK inhibitors resulted in loss of CDK1 prowith this reasoning are the observations made by Lahti tein levels in a subpopulation of cells. This was not due to some nonspecific effect of cell cycle inhibition, since et al., showing that ectopic expression of certain PIT- 
